Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Colorectal Neoplasms 6Stomach Neoplasms 3Pain, Postoperative 3Breast Neoplasms 3Neurotoxicity Syndromes 2Neoplasms 2Nasopharyngeal Carcinoma 2Multiple Endocrine Neoplasia Type 1 2Lung Neoplasms 2Delirium 2Colonic Neoplasms 2Warts 1Thoracic Neoplasms 1Spondylitis, Ankylosing 1Spinal Cord Neoplasms 1Skin Diseases 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Pituitary Neoplasms 1Pituitary Diseases 1Peripheral Nervous System Diseases 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms by Site 1Meningioma 1Lymphoma, Follicular 1Low Back Pain 1Fallopian Tube Neoplasms 1

Interventions

Trastuzumab 2toripalimab 1pyrotinib 1Vinblastine 1Transurethral Resection of Bladder 1Thalidomide 1TP protocol 1Sodium Chloride 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Positron Emission Tomography Computed Tomography 1Paclitaxel 1Neoadjuvant Therapy 1Metformin 1Magnetic Resonance Imaging 1Immunohistochemistry 1Esophagectomy 1Endoscopy 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Diffusion Magnetic Resonance Imaging 1Dexamethasone 1Decitabine 1Cytarabine 1Cisplatin 1Chemoradiotherapy 1Cell-Free Nucleic Acids 1Carboplatin 1Bortezomib 1Blood Specimen Collection 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Pathologic Complete Response × Sodium Chloride × Clear all
NCT04781725 2021-11-17

INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer

Ottawa Hospital Research Institute

Phase 2 Unknown
90 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡